Effects of head and extracranial injuries on serum protein S100B levels in trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 56, Issue 6, 2004, Pages 1229-1234

  Savola, Olli ^a   Pyhtinen, Juhani ^a   Leino, Tuomo K ^a   Siitonen, Simo ^b   Niemelä, Onni ^c   Hillbom, Matti ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH DEFENCE FORCES   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Brain injury; Extracranial injury; S100B

Indexed keywords

PROTEIN S100B;

ADULT; ARTICLE; BRAIN INJURY; DISEASE MARKER; FEMALE; HEAD INJURY; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS;

EID: 3142626380     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000096644.08735.72     Document Type: Article

References (28)

1. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery. 1999;45:468-476.
2. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum s-100B protein in severe head injury. Neurosurgery. 1999;45:477-483.
3. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma. 1999;47:1126-1130.
4. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma. 2000;17:113-122.
5. Kato K, Kimura S. S100a0 (αα) protein is mainly located in the heart and striated muscles. Biochim Biophys Acta. 1985;842:146-150.
6. Hidaka H, Endo T, Kawamoto S, et al. Purification and characterization of adipose tissue S-100b protein. J Biol Chem. 1983;258:2705-2709.
7. Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest. 1987;57:489-498.
8. Anderson RE, Hansson L-O, Nilsson O, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48:1255-1258.
9. King NS, Crawford S, Wenden JF, Moss NE, Wade DT. Measurement of post-traumatic amnesia: how reliable is it? J Neurol Neurosurg Psychiatry. 1997;62:38-42.
10. Marshall LF, Marshall SB, Klauber MR, et al. A new classification of head injury based on computed tomography. J Neurosurg. 1991;75(suppl):S14-S20.
11. Siitonen S. Effects of In-Flight Gz Acceleration on Military Aviators Using Modern Anti-G Garments [thesis]. Kuopio, Finland: Kuopio University Publications D, Medical Sciences 204;2000.
12. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial 100 and NSE serum measurements after severe head injury. Acta Neurochir. 1997;139:1161-1165.
13. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. J Neurosurg. 1999;13:56-59.
14. Raabe A, Grolms C, Keller M, Döhnert J, Sorge O, Seifert V. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir. 1998;140:787-792.
15. Ingebrigtsen T, Romner B, Marup-Jensen S, et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj. 2000;14:1047-1055.
16. Ingebritsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry. 1995;59:103-104.
17. Herrman M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry. 2001;70:95-100.
18. Waterloo K, Ingebritsen T, Romner B. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir. 1997;139:26-32.
19. Savola O, Hillbom M. Early predictors of post-concussion symptoms in patients with mild head injury. Eur J Neurol. 2003:10:175-181.
20. Herrmann M. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;49:1272-1273.
21. Raabe A. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;49:1491-1492.
22. Romner B, Ingebrigtsen T. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;49:1490.
23. Rothoerl RD, Woertgen C. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;49:1490-1491.
24. Herrmann M, Curio N, Jost S, et al. Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci. 1999;14:109-114.
25. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. J Trauma. 1998;45:765-767.
26. Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma. 2000;8:641-647.
27. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: a role for protein S-100B? J Neurol Neurosurg Psychiatry. 2002;73:542-546.
28. Stiell IG, Wells GA, Vandemheen K, et al. The Canadian CT head rule for patients with minor head injury. Lancet. 2001;357:1391-1396.